期刊文献+

小儿日间手术中瑞芬太尼复合丙泊酚麻醉诱导对喉罩置入效果的影响 被引量:1

在线阅读 下载PDF
导出
摘要 目的探讨小儿日间手术中不同剂量瑞芬太尼复合标准剂量丙泊酚麻醉诱导对喉罩置入效果的影响。方法将手术患儿90例随机分为三组,均辅以2.5 mg/kg丙泊酚麻醉诱导,A、B、C组分别静注瑞芬太尼0.4、0.6、0.8μg/kg后插入喉罩。评价患儿张口度满意率、喉罩置入效果,记录麻醉诱导前(T1)、面罩吸氧诱导后(T2)、喉罩置入完成即刻(T3)、喉罩置人后2 min(T4)、手术结束(T5)时MAP、HR、PETCO2及术后不良反应。结果与A组比较,B、C组张口度满意率较高(P<0.05),喉罩置入失败率较低(P<0.01),B、C组间无明显差异;三组T2时MAP、HR、PETCO2均明显低于T1(P均<0.01),B、C组HR明显降低于A组,C组明显低于B组(P<0.05或P<0.01),T3、T4、T5与T1无显著差异;术后未见明显不良反应。结论2.5 mg/kg丙泊酚复合0.6μg/kg瑞芬太尼麻醉诱导喉罩置入效果最佳。
出处 《山东医药》 CAS 北大核心 2009年第15期102-103,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Hui JK, Cfitchley LA, Karmakar MK, et al. Co-adminlstration of alfentanil-propofol improves laryngeal mask airway insertion compared to fentanyl-propofol [ J]. Can J Anaesth ,2002,49 (5) :508 -512.
  • 2Park HJ,Lee JR,Kim CS, et al. Remifentanil halves the EC50 of propofol for successful insertion of the laryngeal mask airway and laryngeal tube in pediatric patients[ J ]. Anesth Analg,2007,105 (1) : 57-61.
  • 3Smith I, White PF, Nathanson M, et al. Propofol. An update on its clinical use[ J]. Anesthesiology, 1994,81 (4) : 1005-1043.
  • 4Kwak HJ, Kim JY, Kim YB, et al. The optimum holus dose of 1emlfontanil to facilitate laryngeal mask airway insertion with a single standard dose[ J]. Anaesthesia,2008,63 ( 9 ) :954-958.
  • 5邱鹏,吕金,陈卫民.瑞芬太尼在小儿麻醉中的药理及应用[J].日本医学介绍,2006,27(12):569-572. 被引量:8
  • 6李申一,钱若筠,胡芸,黄建成,王晓军,雷毅,赵华.丙泊酚伍用瑞芬太尼用于小儿扁桃体联合腺样体切除术的麻醉效果[J].广东医学,2007,28(7):1069-1071. 被引量:8

二级参考文献33

  • 1李申一,钱若筠,徐世元,黄建成,雷毅,赵华,王晓军.瑞芬太尼-丙泊酚联合靶控注射麻醉用于悬雍垂腭咽成形术[J].广东医学,2006,27(2):221-223. 被引量:5
  • 2李申一,雷毅,徐世元,王晓军,赵涛,赵华,彭铖,李杉.悬雍垂腭咽成型术的麻醉处理(附786例报告)[J].南方医科大学学报,2006,26(11):1673-1674. 被引量:2
  • 3Davis PJ, Ross AK, Stiller BL, et al. Pharmacokinetics of remifentanil in anesthetized children 2 - 12 years of age.Anesth Analg,1995, 80(2) : S93.
  • 4Glass PSA, Gan TJ, Howell S. A review of the pharmacokinetics and pharma-codynamics of remifentanil. Anesth Analg,1999, 89(4) S7-14.
  • 5Egan TD, Lemmens HJM, Fiset P, et at. The pharmacokinetics of the new short-acting opioid remifentanil(GI87084B) in healthy adult male volunteers. Anesthesiology,1993,79(5) : 881 -892.
  • 6Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI870848) and its major metabolite( G190291 ) in patients undergoing elective inpatient surgery.Anesthesiology, 1993,79 (5) : 893 - 903.
  • 7Kapila A, Glass PSA, Jaeobs JR, et al. Measured context-sensitive half times of remifentanil and alfentanil, Anesthesiology,1995,83(5) :968 -975.
  • 8Kan BE, Hughes SC, Rosen MA, et al.Intravenous remifentanil placental transfer, maternal and ueonatal effects. Anesthesiology,1998,88(6) :1467 - 1474.
  • 9Bedard JM, Richardson MG, Wissler RN. General anesthesia with remifentanil for caesarean section in a parturient with an acoustic neuroma. Can J Anesth, 1999,46(6) :570 -580
  • 10Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996,84(4) : 812-820

共引文献14

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部